CRISPR makes prostate cancer vulnerable to immunotherapy
admin
ساينس ديلي - الكل
27 يوليو, 2026
Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors.
